Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on August 8
17. Juli 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
RAMAT GAN, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
11. Juli 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, July 11, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson
01. Juli 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
Liver cirrhosis treatment global market is estimated to reach $29.2 billion by 2030 Ramat Gan, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a...
Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
21. November 2023 13:53 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite Announces Exercise of Warrants for Cash Proceeds of $10 Million
20. Dezember 2021 16:05 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite BioPharma Announces Pricing of $5 Million Public Offering
10. Februar 2020 14:48 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Can-Fite BioPharma Announces $6 Million Registered Direct Offering
20. Mai 2019 14:06 ET
|
Can-Fite BioPharma Ltd.
PETACH TIKVA, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs...